Impact of Obesity and Bariatric Surgery on Metabolic Enzymes and P-glycoprotein Activity using Geneva Cocktail Approach
Authors:
- Hengameh GhasimHGHengameh Ghasim
- Mohammadreza RouiniMohammadreza Rouini
- Saeed SafariSSSaeed Safari
- Farnoosh LartiFLFarnoosh Larti
- Mohammadreza KhoshayandMKMohammadreza Khoshayand
- Kheirollah GholamiKGKheirollah Gholami
- Navid NeyshaburinezhadNNNavid Neyshaburinezhad
- Yvonne GloorYGYvonne Gloor
- Youssef DaaliYoussef Daali
- Yalda H. ArdakaniYAYalda H. Ardakani
Preprint
- 30 May 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The inter-individual variability of CYP450s enzyme activity may be reduced by comparing the effects of bariatric surgery on CYP-mediated drug elimination in comparable patients before and after surgery. The current research will use a low-dose phenotyping cocktail to simultaneously evaluate the activities of six CYP isoforms and P-gp.The results showed that following weight reduction after surgery, the activity of all enzymes increased compared to the obese period, which was statistically significant in the case of CYP3A, CYP2B6, CYP2C9, and CYP1A2. Furthermore, the activity of P-gp after surgery decreased without reaching a statistical significance (p-value>0.05). Obese individuals had decreased CYP3A and CYP2D6 activity than the control group, albeit only CYP3A was statistically important. In addition, there was a trend to increase activity for CYP1A2, CYP2B6, CYP2C9, and CYP2C19 in obese patients compared to the control group, without reaching statistical insignificance (p-value≥0.05). After six months (at least), all enzymes and the P-gp pump activity were significantly higher than the control group except for CYP2D6.Ultimately, a greater comprehension of phenoconversion can aid in altering the patient's treatment. Further studies are required to confirm the changes in the metabolic ratios of probes after bariatric surgery to demonstrate the findings' clinical application. As a result, the effects of inflammation-induced phenoconversion on medication metabolism may differ greatly across persons and drug CYP pathways. It is essential to apply these results to the clinic to recommend dose adjustments.Keywords
All Related Versions
This publication has 39 references indexed in Scilit:
- Liquid Biopsy for Patient Characterization in Cardiovascular Disease: Verification against Markers of Cytochrome P450 and P‐Glycoprotein ActivitiesClinical Pharmacology & Therapeutics, 2022
- Evaluation of phenoconversion phenomenon in obese patients: the effects of bariatric surgery on the CYP450 activity “a protocol for a case–control pharmacokinetic study”Journal of Diabetes & Metabolic Disorders, 2021
- Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6, OPRM1, and COMT Genotypes and Select Opioid TherapyClinical Pharmacology & Therapeutics, 2021
- Impact of Acute Inflammation on Cytochromes P450 Activity Assessed by the Geneva CocktailClinical Pharmacology & Therapeutics, 2020
- Clinical Pharmacogenetics Implementation Consortium Guideline (CPIC) for CYP2C9 and Nonsteroidal Anti‐Inflammatory DrugsClinical Pharmacology & Therapeutics, 2020
- Modulation of CYP450 Activities in Patients With Type 2 DiabetesClinical Pharmacology & Therapeutics, 2019
- Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2B6 and Efavirenz‐Containing Antiretroviral TherapyClinical Pharmacology & Therapeutics, 2019
- Influence of Obesity and Type 2 Diabetes Mellitus on the Pharmacokinetics of Tramadol After Single Oral Dose AdministrationEuropean Journal of Drug Metabolism and Pharmacokinetics, 2019
- A liquid chromatography-tandem mass spectrometry analysis of nine cytochrome P450 probe drugs and their corresponding metabolites in human serum and urineAnalytical and Bioanalytical Chemistry, 2016
- The Basel Cocktail for Simultaneous Phenotyping of Human Cytochrome P450 Isoforms in Plasma, Saliva and Dried Blood SpotsClinical Pharmacokinetics, 2014